DE69214277T2 - Dna-sequenzen, die für die virulente eigenschaft von -i(streptococcus suis) kodieren, und teile davon, polypeptide und antikörper die sich davon ableiten und deren verwendung für diagnose und prophylaxe der infektion mit streptococcus suis in säugetieren, insbesondere in menschen - Google Patents

Dna-sequenzen, die für die virulente eigenschaft von -i(streptococcus suis) kodieren, und teile davon, polypeptide und antikörper die sich davon ableiten und deren verwendung für diagnose und prophylaxe der infektion mit streptococcus suis in säugetieren, insbesondere in menschen

Info

Publication number
DE69214277T2
DE69214277T2 DE69214277T DE69214277T DE69214277T2 DE 69214277 T2 DE69214277 T2 DE 69214277T2 DE 69214277 T DE69214277 T DE 69214277T DE 69214277 T DE69214277 T DE 69214277T DE 69214277 T2 DE69214277 T2 DE 69214277T2
Authority
DE
Germany
Prior art keywords
polypeptides
parts
diagnosis
polypeptide
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69214277T
Other languages
English (en)
Other versions
DE69214277D1 (de
Inventor
Hilda Smith
Uri Vecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetoquinol SA
Original Assignee
Stichting Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centraal Diergeneeskundig Instituut filed Critical Stichting Centraal Diergeneeskundig Instituut
Application granted granted Critical
Publication of DE69214277D1 publication Critical patent/DE69214277D1/de
Publication of DE69214277T2 publication Critical patent/DE69214277T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69214277T 1991-03-21 1992-03-19 Dna-sequenzen, die für die virulente eigenschaft von -i(streptococcus suis) kodieren, und teile davon, polypeptide und antikörper die sich davon ableiten und deren verwendung für diagnose und prophylaxe der infektion mit streptococcus suis in säugetieren, insbesondere in menschen Expired - Fee Related DE69214277T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9100510A NL9100510A (nl) 1991-03-21 1991-03-21 Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
PCT/NL1992/000054 WO1992016630A1 (en) 1991-03-21 1992-03-19 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man

Publications (2)

Publication Number Publication Date
DE69214277D1 DE69214277D1 (de) 1996-11-07
DE69214277T2 true DE69214277T2 (de) 1997-03-20

Family

ID=19859048

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214277T Expired - Fee Related DE69214277T2 (de) 1991-03-21 1992-03-19 Dna-sequenzen, die für die virulente eigenschaft von -i(streptococcus suis) kodieren, und teile davon, polypeptide und antikörper die sich davon ableiten und deren verwendung für diagnose und prophylaxe der infektion mit streptococcus suis in säugetieren, insbesondere in menschen

Country Status (14)

Country Link
US (1) US5610011A (de)
EP (1) EP0575497B1 (de)
JP (1) JP2776633B2 (de)
CN (1) CN1055500C (de)
AT (1) ATE143693T1 (de)
AU (1) AU659637B2 (de)
CA (1) CA2105057C (de)
DE (1) DE69214277T2 (de)
DK (1) DK0575497T3 (de)
ES (1) ES2094907T3 (de)
GR (1) GR3022052T3 (de)
NL (1) NL9100510A (de)
NZ (1) NZ242037A (de)
WO (1) WO1992016630A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5726016A (en) * 1995-01-18 1998-03-10 The Trustees Of The University Of Pennsylvania Compositions and methods for diagnosis of diseases associated with actinobacillus actinomycetemcomitans infection
WO1996023896A1 (en) * 1995-01-30 1996-08-08 Peter Truog Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
ES2512496T3 (es) 1998-07-22 2014-10-24 Stichting Dienst Landbouwkundig Onderzoek Vacunas y pruebas de diagnóstico de Streptococcus suis
EP1205552A1 (de) 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Streptokokkenvirulenz mit ORF aus Streptococcus suis
US6905816B2 (en) 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
JP4275413B2 (ja) 2001-02-02 2009-06-10 イーデー−レーリスタット，インスティチュート フォール ディールハウデレイ エン ディールゲゾントヘイト ベー．フェー． ストレプトコッカス・スイスの環境的に調節された遺伝子
DK1943342T3 (en) 2005-09-02 2016-07-25 Valorisation-Recherche Ltd Partnership STREPTOCOCCUS SUIS POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND THEIR USE IN DIAGNOSTIC USES vaccination and
CN100388952C (zh) * 2006-04-25 2008-05-21 范红结 一种链球菌重组亚单位疫苗及其制备方法
CN100449005C (zh) * 2006-06-29 2009-01-07 中国检验检疫科学研究院动植物检疫研究所 应用于猪链球菌2型致病性检测的多重荧光pcr检测试剂及方法
CN100449006C (zh) * 2006-08-10 2009-01-07 中国检验检疫科学研究院动植物检疫研究所 应用于猪链球菌2型胞外因子(ef)荧光pcr检测的引物和探针序列
EP2023143A1 (de) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogene Streptokokkus-Proteine
CN101613400B (zh) * 2008-06-25 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 一种猪链球菌2型表面细胞壁蛋白、其制备方法及用途
CN101613402B (zh) * 2008-06-25 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 一种猪链球菌2型表面蛋白、其制备方法及用途
CN101613399B (zh) * 2008-06-25 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 一种猪链球菌2型表面蛋白、其制备方法及用途
CA2905375A1 (en) * 2013-03-15 2014-09-18 Camas Incorporated Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
CN104762244B (zh) * 2015-02-04 2017-09-15 中国农业科学院哈尔滨兽医研究所 猪链球菌SBP_bac_5基因缺失株及其构建方法与应用
CN107805660B (zh) * 2017-12-08 2021-11-26 江汉大学 一种猪链球菌小种分离鉴定方法
GB2587228B (en) * 2019-09-20 2021-10-27 Protein Ark Ltd Biological sample purification apparatus, use of the same, and systems comprising the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784948A (en) * 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
CA2009708A1 (en) * 1989-02-13 1990-08-13 Jane D. Madonna Nucleic acid probe for the detection of salmonella human pathogens

Also Published As

Publication number Publication date
US5610011A (en) 1997-03-11
ATE143693T1 (de) 1996-10-15
GR3022052T3 (en) 1997-03-31
EP0575497B1 (de) 1996-10-02
NZ242037A (en) 1997-03-24
EP0575497A1 (de) 1993-12-29
CN1065490A (zh) 1992-10-21
ES2094907T3 (es) 1997-02-01
AU659637B2 (en) 1995-05-25
CN1055500C (zh) 2000-08-16
NL9100510A (nl) 1992-10-16
WO1992016630A1 (en) 1992-10-01
DE69214277D1 (de) 1996-11-07
JP2776633B2 (ja) 1998-07-16
JPH06505390A (ja) 1994-06-23
DK0575497T3 (da) 1996-11-18
CA2105057A1 (en) 1992-09-22
CA2105057C (en) 2000-05-02
AU1546492A (en) 1992-10-21

Similar Documents

Publication Publication Date Title
DE69214277D1 (de) Dna-sequenzen, die für die virulente eigenschaft von -i(streptococcus suis) kodieren, und teile davon, polypeptide und antikörper die sich davon ableiten und deren verwendung für diagnose und prophylaxe der infektion mit streptococcus suis in säugetieren, insbesondere in menschen
BR9914066A (pt) Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae
ES2101834T3 (es) Anticuerpos anti-cd4 que bloquean sincitios inducidos por vih.
TR200200633T2 (tr) Yeni streptococcus antijenleri
DE69201441D1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
DK0730606T3 (da) Hu-B1.219, en hidtil ukendt human hæmatopoietinreceptor
BR9507758A (pt) Fração de copolímero-1 e composição para o tratamento de esclerose múltipla
EP0378641A4 (en) Novel antimicrobial peptide, compositions containing same and uses thereof
ES2147178T3 (es) Dominio de union a cd2 del antigeno 3 asociado con la funcion linfocitica.
ATE513915T1 (de) Verbindungen und verfahren zur immuntherapie und diagnose von tuberkulose
WO1995014781A3 (en) Methods for diagnosing early lyme disease
ATE356206T1 (de) Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen
EP1542732A4 (de) Fusionsproteine aus mycobakterium tuberculosis
HU9401511D0 (en) Vaccine against streptococcus suls infection
ATE112783T1 (de) Stressprotein aus bakterien.
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
BR9812791A (pt) Sequências de ácido nucléico associadas à virulência e seu uso
ATE299182T1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
ATE214399T1 (de) Mycobacteriumprotein und dessen verwendung
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
ATE120488T1 (de) Diagnose für bösartige hyperthermia im schwein.
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ATE411390T1 (de) Synthetische säugetier alpha-n- acetylglukosaminidase und dafür kodierende genetische sequenzen
EP0367641A3 (en) Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines
WO1994003605A3 (en) Compositions and methods for detecting human herpesvirus 6 strain z29

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: VETOQUINOL S.A., LURE, FR

8339 Ceased/non-payment of the annual fee